Cellectar Biosciences - 14 Year Stock Price History | CLRB

Historical daily share price chart and data for Cellectar Biosciences since 2005 adjusted for splits. The latest closing stock price for Cellectar Biosciences as of July 19, 2019 is 2.10.
  • The all-time high Cellectar Biosciences stock price is 1034280.00, which is 49251328.6% above the current share price.
  • The Cellectar Biosciences 52-week high stock price is 6.70, which is 219% above the current share price.
  • The Cellectar Biosciences 52-week low stock price is 1.29, which is 38.6% below the current share price.
  • The average Cellectar Biosciences stock price for the last 52 weeks is 2.39.
Cellectar Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.1511 1.5800 2.8500 1.5800 2.1000 35.48%
2018 7.0838 13.7000 13.7000 1.2900 1.5500 -88.69%
2017 17.2692 12.8000 26.6000 11.2000 13.7000 12.30%
2016 31.0365 73.2000 76.1500 10.5000 12.2000 -83.40%
2015 250.6595 306.0100 355.0000 68.5000 73.5000 -76.21%
2014 552.5469 760.0000 840.0000 198.9500 309.0000 -58.24%
2013 910.9524 1480.0000 1580.0000 600.0000 740.0000 -50.00%
2012 1921.5200 900.0000 4000.0000 860.0000 1480.0000 68.18%
2011 4315.7937 12240.0000 15300.0000 740.0000 880.0000 -90.41%
2010 113632.8571 908820.0000 908820.0000 6120.0000 9180.0000 -98.82%
2009 215997.1429 143820.0000 777240.0000 104040.0000 777240.0000 440.43%
2008 158587.8261 186660.0000 244800.0000 67320.0000 143820.0000 -21.67%
2007 260855.8566 275400.0000 416160.0000 131580.0000 183600.0000 -31.82%
2006 374575.6972 581400.0000 691560.0000 192780.0000 269280.0000 -56.44%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.020B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.82
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.28
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.543B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.04
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33
MRI INTERVENTNS (MRIC) United States $0.052B 0.00